Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

4.12USD
18 Apr 2019
Change (% chg)

$-0.17 (-3.96%)
Prev Close
$4.29
Open
$4.31
Day's High
$4.34
Day's Low
$3.95
Volume
87,571
Avg. Vol
90,888
52-wk High
$14.62
52-wk Low
$3.55

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: 1.28
Market Cap(Mil.): $431.41
Shares Outstanding(Mil.): 104.71
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 103.27 57.80
EPS (TTM): -0.98 -- --
ROI: -41.61 7.81 11.82
ROE: -42.46 7.87 12.64

Earnings vs. Estimates